T1	Participants 202 255	prostate cancer and benign conditions of the prostate
T2	Participants 597 607	10,865 men
T3	Participants 650 685	1202 men with PSA levels of 4 ng/mL
T4	Participants 1231 1246	prostate cancer
T5	Participants 1200 1217	1202 men studied,
